Brain-derived neurotrophic factor and glutathione peroxidase as state biomarkers in alcohol use disorder patients undergoing detoxification

Medicine (Baltimore). 2020 Apr;99(17):e19938. doi: 10.1097/MD.0000000000019938.

Abstract

The pathophysiology of alcohol use disorder (AUD) is not totally clear. The aim of this study was to investigate the serum levels of brain-derived neurotrophic factor (BDNF) and oxidative stress markers in AUD patients during alcohol detoxification. Evaluation of changes in BDNF, glutathione peroxidase (GPX), catalase, superoxide dismutase, thiobarbituric acid reactive substances, 8-hydroxy 2'-deoxyguanosine, PCC and S100B were carried out.14 AUD inpatients and 20 healthy control subjects were recruited for this study. The serum BDNF, S100B and oxidative stress markers were measured with assay kits.Serum levels of catalase, GPX, PCC and 8-hydroxy 2'-deoxyguanosine were significantly higher in the AUD group subjects than in the controls (P < .05). However, BDNF levels were lower in the AUD group than in the controls (P < .05). After alcohol detoxification treatment, the GPX levels in the AUD group dropped (P < .05) and the BDNF levels rose (P < .05).The results suggest that serum BDNF and GPX levels might be state biomarkers for AUD patients undergoing alcohol detoxification.

MeSH terms

  • Adult
  • Alcoholism / blood*
  • Alcoholism / drug therapy*
  • Alcoholism / physiopathology
  • Biomarkers / analysis
  • Biomarkers / blood
  • Brain-Derived Neurotrophic Factor / analysis*
  • Brain-Derived Neurotrophic Factor / blood
  • Female
  • Glutathione Peroxidase / analysis*
  • Glutathione Peroxidase / blood
  • Humans
  • Inactivation, Metabolic / drug effects
  • Inactivation, Metabolic / physiology*
  • Male
  • Middle Aged

Substances

  • Biomarkers
  • Brain-Derived Neurotrophic Factor
  • BDNF protein, human
  • Glutathione Peroxidase